2 not yet recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Complicated Urinary Tract Infections(cUTI): new trials by email Literature Review of Complicated Urinary Tract Infections(cUTI) trials Research Report on Complicated Urinary Tract Infections(cUTI)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| This is a Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ertapenem-zidebactam Versus Ceftazidime-Avibactam in the Treatment of Hospitalized Adult Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis Ertapenem-zidebactam, Ceftazidime-Avibactam, Ertapenam-Zidebactam - Complicated Urinary Tract Infections(cUTI), Acute Pyelonephritis | Phase 2 | Not yet recruiting | Wockhardt | 279 | 2026-09-30 | 2026-09-24 |
| Evaluation of the Safety, Tolerability and Pharmacokinetics of TUL108 for Injection in Healthy Participants (SAD/ MAD) TUL108, Placebo - Complicated Urinary Tract Infections(cUTI) | Phase 1 | Not yet recruiting | Zhuhai United Laboratories Co., Ltd. | 72 | 2026-07-30 | 2026-07-22 |
avibactam, ceftazidime drug combination (1)
Wockhardt (1) · Zhuhai United Laboratories Co., Ltd. (1)
China (1) · India (1)
Jing Zhang (1)